Decision Diagnostics ROA 2010-2011 | DECN
Current and historical return on assets (ROA) values for Decision Diagnostics (DECN) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Decision Diagnostics ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2011-09-30 | $0.00B | $0.01B | -20.00% |
| 2011-06-30 | $0.00B | $0.01B | -21.05% |
| 2011-03-31 | $0.00B | $0.01B | -21.05% |
| 2010-12-31 | $0.00B | $0.01B | -22.22% |
| 2010-09-30 | $0.00B | $0.00B | 0.00% |
| 2010-06-30 | $0.00B | $0.01B | 0.00% |
| 2010-03-31 | $0.00B | $0.00B | 28.57% |
| 2009-12-31 | $0.00B | $0.00B | 30.77% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.000B | $0.000B |
| Decision Diagnostics Corp. is engaged in developing products that offer solutions in medical care and management by providing physicians with information at the point of care. The Company uses smart phones which allow physicians to carry, access and update their patients' histories, medication data, and best care guidelines at the point of care. Decision Diagnostics Corp. is a leading provider of prescription drugs, home testing products for the chronically ill, a leading fulfillment provider of direct to patient diabetes programs, and a leading developer of revolutionary cell phone centric e-health products and technologies. Decision Diagnostics Corp., formerly known as Instacare Corp., is based in Westlake Village, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $37.687B | 52.05 |
| Tempus AI (TEM) | United States | $9.349B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $7.785B | 125.14 |
| Inspire Medical Systems (INSP) | United States | $4.759B | 92.44 |
| IRhythm Technologies (IRTC) | United States | $3.404B | 0.00 |
| Privia Health (PRVA) | United States | $2.840B | 212.82 |
| Enovis (ENOV) | United States | $1.994B | 12.34 |
| Schrodinger (SDGR) | United States | $1.883B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.763B | 0.00 |
| Omnicell (OMCL) | United States | $1.471B | 31.72 |
| Phreesia (PHR) | United States | $1.461B | 0.00 |
| Azenta (AZTA) | United States | $1.216B | 56.62 |
| 10x Genomics (TXG) | United States | $1.025B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.583B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.560B | 0.00 |
| Talkspace (TALK) | United States | $0.532B | 316.00 |
| Veradigm (MDRX) | United States | $0.457B | 0.00 |
| Standard BioTools (LAB) | United States | $0.440B | 0.00 |
| TruBridge (TBRG) | United States | $0.389B | 0.00 |
| Claritev (CTEV) | United States | $0.373B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.286B | 0.00 |
| Pulmonx (LUNG) | United States | $0.212B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.211B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.204B | 0.00 |
| American Well (AMWL) | United States | $0.114B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.094B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.085B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.082B | 0.00 |
| CareCloud (CCLD) | United States | $0.077B | 3.31 |
| 111 (YI) | China | $0.072B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.063B | 0.00 |
| HeartBeam (BEAT) | United States | $0.061B | 0.00 |
| Outset Medical (OM) | United States | $0.041B | 0.00 |
| Zepp Health (ZEPP) | China | $0.040B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |